ask="18.77"
ask_size="500"
average_daily_volume="143858"
bid="14.55"
bid_size="1000"
book_value="6.55"
change="+0.19"
change_from_200_day_moving_average="1.63"
change_from_50_day_moving_average="0.60"
change_from_52_week_high="-2.22"
change_From_52_week_low="5.26"
change_in_percent="+1.11%"
close="17.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.01"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11581000"
high="17.77"
high_52_weeks="19.50"
last_trade_date="2/17/2017"
last_trade_price="17.28"
last_trade_size="11807"
last_trade_time="4:00pm"
low="16.98"
low_52_weeks="12.02"
market_capitalization="379.85M"
moving_average_200_day="15.65"
moving_average_50_day="16.68"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.83"
open="17.11"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+10.39%"
percent_change_from_50_day_moving_average="+3.58%"
percent_change_from_52_week_high="-11.38%"
percent_change_from_52_week_low="+43.76%"
previous_close="17.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.61"
price_per_sales="354.74"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="73275"
weeks_range_52="12.02 - 19.50"
